Comparison of COPD symptoms and severity in two groups living at 200 and 1200 metres above the sea

G. Andonovski, Z. Stojanovski, B. Janackov, J. Minov, D. Andjelkovic, A. Lazarevska (Skopje, Kumanovo, Fyrom)

Source: Annual Congress 2007 - Clinical aspects of COPD II
Session: Clinical aspects of COPD II
Session type: Thematic Poster Session
Number: 600
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Andonovski, Z. Stojanovski, B. Janackov, J. Minov, D. Andjelkovic, A. Lazarevska (Skopje, Kumanovo, Fyrom). Comparison of COPD symptoms and severity in two groups living at 200 and 1200 metres above the sea. Eur Respir J 2007; 30: Suppl. 51, 600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Normal values for sleep respiratory poligraphy in children 4-9 years old living at 2,560 meters above sea level
Source: Sleep and Breathing Conference 2021
Year: 2021




Altitude related adverse health effects in lowlanders with COPD travelling to 3200m
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016

Effect of travelling to 2590m on 6-minute walk distance, blood gases and symptoms of acute mountain sickness in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Comparison of 800 μg once vs. 400 μg twice daily inhaled budesonide in patients with moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 49s
Year: 2001

Comparison of ciclesonide 160 versus 640 μg per day in patients with severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 206s
Year: 2006

Blood eosinophil levels and exacerbations in a cohort of biomass and tobacco-related COPD patients at high altitude (2600 m)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Ventilation parameters in asthmatic children after one week at 1400 meters altitude
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012


Evaluation of the relationship between the activity of daily living and dyspnoea in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 182s
Year: 2005

Predictors of activities of daily living in patients with COPD
Source: International Congress 2016 – Measuring physical activity in chronic respiratory disease
Year: 2016

Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016

Relation between daily living activities, alexithymia and six minute walking test in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Year: 2008


Comparison of physical activity level, activities of daily living, and depression between the patients with asthma and bronchiectasis
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017

Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Reference values for maximal respiratory pressures in healthy sedentary and active individuals 20-80 years of the city of Manaus
Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient
Year: 2016


Dexamethasone treatment for patients with COPD when they travel to high altitude
Source: International Congress 2019 – Advances in chronic obstructive pulmonary disease and asthma
Year: 2019


Effects of a daytrip to high altitude (2500m) in pulmonary hypertension.
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Changes in COPD symptom control questionnaire (CCQ) scores after seven days of treatment with prednisolone of acute exacerbations in hospitalised patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003

Activities of daily living: a comparison between patients with COPD and ILD
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1
Year: 2020


Predictors of the level of daily activities for different GOLD COPD stages
Source: Eur Respir J 2007; 30: Suppl. 51, 127s
Year: 2007

COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006